Indonesia’s Health Ministry has moved to reassure citizens that medicine prices will remain affordable despite recent rupiah depreciation. Officials state they are monitoring the situation closely and implementing measures to mitigate the impact of currency fluctuations on pharmaceutical costs. These measures include encouraging the use of domestically produced generic drugs and optimizing the pharmaceutical supply chain. The Ministry emphasized that price increases, if any, will be within reasonable limits and will not significantly burden the public. They are collaborating with pharmaceutical companies and distributors to maintain price stability. The government also highlighted its commitment to ensuring access to essential medicines for all Indonesians, particularly vulnerable populations. Further details on specific strategies will be announced in the coming weeks.